Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI102173

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. New Product Launches, by Key Market Players
2. Prevalence by Disease Indication, By Key Countries/ Region, 2024
3. Incidence of Cancer, By Key Countries/ Key Region,2024
4. Key industry Developments - Mergers, Acquisitions and Partnerships
5. Overview of Biomarkers In Personalized Medicine
Global Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals and Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2024)
3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Thermo Fisher Scientific
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Bio-Rad Laboratories, Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. CENTOGENE N.V.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Axon Medchem
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Sino Biological Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. R&D System
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. BioVision Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Myriad RBM
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  11. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendation

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. New Product Launches, by Key Market Players
2. Prevalence by Disease Indication, By Key Countries/ Region, 2024
3. Incidence of Cancer, By Key Countries/ Key Region,2024
4. Key industry Developments - Mergers, Acquisitions and Partnerships
5. Overview of Biomarkers In Personalized Medicine
Global Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals & Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Biomarkers Market Analysis, Insights and Forecast, 2019-2032
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biotechnology Companies
  2. Diagnostics & Research Laboratories
  3. Hospitals and Specialty Clinics
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2024)
3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. F. Hoffmann-La Roche Ltd.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Thermo Fisher Scientific
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Bio-Rad Laboratories, Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. CENTOGENE N.V.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Axon Medchem
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Sino Biological Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. R&D System
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. BioVision Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Myriad RBM
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  11. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendation

Read Less

List of Figures

Figure 1: Global Biomarkers Market Revenue Breakdown (US$ Mn, %) by Region, 2024 & 2032

Figure 2: Global Biomarkers Market Value Share (%), by Indication 2024 & 2032

Figure 3: Global Biomarkers Market Forecast (US$ Mn), by Oncology, 2019-2032

Figure 4: Global Biomarkers Market Forecast (US$ Mn), by Cardiology, 2019-2032

Figure 5: Global Biomarkers Market Forecast (US$ Mn), by Neurology, 2019-2032

Figure 6: Global Biomarkers Market Forecast (US$ Mn), by Others, 2019-2032

Figure 7: Global Biomarkers Market Value Share (%), by End User, 2024 & 2032

Figure 8: Global Biomarkers Market Forecast (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2019-2032

Figure 9: Global Biomarkers Market Forecast (US$ Mn), by Diagnostics and Research Laboratories, 2019-2032

Figure 10: Global Biomarkers Market Forecast (US$ Mn), by Hospitals and Specialty Clinics, 2019-2032

Figure 11: Global Biomarkers Market Forecast (US$ Mn), by Others, 2019-2032

Figure 12: Global Biomarkers Market Value (US$ Mn), by Region, 2024 & 2032

Figure 13: North America Biomarkers Market Value (US$ Mn), by Indication, 2024 & 2032

Figure 14: North America Biomarkers Market Value Share (%), by Indication, 2024

Figure 15: North America Biomarkers Market Value (US$ Mn), by End User, 2024 & 2032

Figure 16: North America Biomarkers Market Value Share (%), by End User, 2024

Figure 17: North America Biomarkers Market Value (US$ Mn), By Country, 2024 & 2032

Figure 18: North America Biomarkers Market Value Share (%), By Country, 2024

Figure 19: Europe Biomarkers Market Value (US$ Mn), by Indication, 2024 & 2032

Figure 20: Europe Biomarkers Market Value Share (%), by Indication, 2024

Figure 21: Europe Biomarkers Market Value (US$ Mn), by End User, 2024 & 2032

Figure 22: Europe Biomarkers Market Value Share (%), by End User, 2024

Figure 23: Europe Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 24: Europe Biomarkers Market Value Share (%), By Country/ Sub-region, 2024

Figure 25: Asia Pacific Biomarkers Market Value (US$ Mn), by Indication, 2024 & 2032

Figure 26: Asia Pacific Biomarkers Market Value Share (%), by Indication, 2024

Figure 27: Asia Pacific Biomarkers Market Value (US$ Mn), by End User, 2024 & 2032

Figure 28: Asia Pacific Biomarkers Market Value Share (%), by End User, 2024

Figure 29: Asia Pacific Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 30: Asia Pacific Biomarkers Market Value Share (%), By Country/ Sub-region, 2024

Figure 31: Latin America Biomarkers Market Value (US$ Mn), by Indication, 2024 & 2032

Figure 32: Latin America Biomarkers Market Value Share (%), by Indication, 2024

Figure 33: Latin America Biomarkers Market Value (US$ Mn), by End User, 2024 & 2032

Figure 34: Latin America Biomarkers Market Value Share (%), by End User, 2024

Figure 35: Latin America Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 36: Latin America Biomarkers Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Middle East & Africa Biomarkers Market Value (US$ Mn), by Indication, 2024 & 2032

Figure 38: Middle East & Africa Biomarkers Market Value Share (%), by Indication, 2024

Figure 39: Middle East & Africa Biomarkers Market Value (US$ Mn), by End User, 2024 & 2032

Figure 40: Middle East & Africa Biomarkers Market Value Share (%), by End User, 2024

Figure 41: Middle East & Africa Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 42: Middle East & Africa Biomarkers Market Value Share (%), By Country/ Sub-region, 2024

Figure 43: Global Biomarkers Market Share (%), By Company, 2024

List of Tables

Table 1: Global Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 2: Global Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019–2032

Table 3: Global Biomarkers Market Revenue (US$ Mn) Forecast, by Region, 2019-2032

Table 4: North America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 5: North America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019-2032

Table 6: North America Biomarkers Market Revenue (US$ Mn) Forecast, By Country, 2019-2032

Table 7: Europe Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 8: Europe Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019-2032

Table 9: Europe Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 10: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 11: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019-2032

Table 12: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 14: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019-2032

Table 15: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2019–2032

Table 17: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2019-2032

Table 18: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 110

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Cardiac Biomarkers Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com